Amgen (AMGN) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

AMGN Amgen

Watchlist

268.930
+6.180+2.35%

Close Apr 19 16:00 ET

270.000
+1.070+0.40%

Post 19:59 ET

144.25BMarket Cap21.53P/E (TTM)

Full Hours

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

How Is The Market Feeling About Amgen?
Amgen's (NYSE:AMGN) short percent of float has fallen 5.77% since its last report. The company recently reported that it has 10.47 million shares sold short, which is 1.96% of all regular shares that
BenzingaApr 19 09:45 ET
Amgen Is Maintained at Neutral by UBS
Amgen Is Maintained at Neutral by UBS
Dow JonesApr 18 07:41 ET
Amgen Price Target Cut to $284.00/Share From $314.00 by UBS
Amgen Price Target Cut to $284.00/Share From $314.00 by UBS
Dow JonesApr 18 07:41 ET
Amgen (AMGN) Suffers a Larger Drop Than the General Market: Key Insights
Yahoo FinanceApr 17 18:00 ET
Express News | Amgen Inc Says CEO Robert a. Bradway's 2023 Total Compensation Was $22.6 Mln Vs $21.4 Mln in 2022 – SEC Filing
Moomoo 24/7Apr 17 16:05 ET
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
Tuesday, Amgen Inc (NASDAQ:AMGN) provided an update regarding the results of the Phase 2a COURSE trial for Tezspire (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD). Tezspire is a re
BenzingaApr 17 14:39 ET

Comments

life is a blessing

Apr 12 10:50

ESPR is the Probably the Most Undervalued Stock on the Market, Offers 2500% Upside. 2 FDA Approved Blockbuster Drugs. Billions in Sales Expected. Buyout Expected.

$Esperion Therapeutics(ESPR.US)$ Esperion (ESPR) stock price has dropped from a recent high of $3.40 a share to $2.31 on FALSE claims of dilution. The price drop offers an amazing buying opportunity.
Huge News On Mar 25.2024 U.S. FDA Approved Broad Labels for NEXLIZET and NEXLETOL, now regular doctors can prescribe and Insurance will...

Carla Lee

Apr 1 22:31

what is your best undervalued stocks?

Investors subscribing to the value investing approach believe it's possible to identify stocks that are trading at a price below their intrinsic value. The idea is that, by investing in these companies before the market corrects, one stands to experience gains when the price of the stock increases to match the true value.
For March 2024, the most undervalued stocks—those with the lowest price-to-earnings (P/E) ratios for each sector—include energy transportat...

PREMOSULTRAA

Mar 8 11:47

OBESITY Will only focus on main players $VKTX $LLY $NVO $AMGN $GPCR

$Viking Therapeutics(VKTX.US)$$Eli Lilly and Co(LLY.US)$$Novo-Nordisk A/S(NVO.US)$$Amgen(AMGN.US)$$Structure Therapeutics(GPCR.US)$
Demand is too high for the obesity drugs but major drug companies unable to keep up with this demand. This will be an opportunity for multiple drug companies to take a pie out of the obesity market.
SubQ likely to be prescribed first for short term weight loss and oral drugs for maintenance. This is not an oncology space ...

Moomoo AI

Mar 1 02:50

Disney, Fox Corp-B, and Warner Bros Discovery's joint venture faces a lawsuit by FuboTV on antitrust grounds. Amgen's weak performance is due to mixed financial forecasts and questions about its weight-loss drug, MariTide. Constellation Energy's strong performance is backed by the IRA's nuclear production tax credit and effective cash flow deployment. Charter Communications' poor performance is due to a surprise loss in internet subscribers and missed quarterly earnings expectations.